AXON Healthcare Investments

Govind Chavada

Dr Govind Chavada


An entrepreneur and practicing physician, Govind’s mission is to transform the healthcare industry by creating an integrated platform for clinicians, scientists and the pharmaceutical industry. He identifies and invests in companies that change medicine by bringing novel drugs, technologies and devices to market. Govind has the medical background to create value for companies from the earliest stage through to clinical trials and regulatory approval. He began his career as a practising Neurologist with a special interest in inflammatory neurological conditions. Govind earned his medical degree from the Baroda Medical college and has a research degree in neuroimmunology from the University of Glasgow.

Vishal Jain

Non Executive Director

Mr. Jain has over a decade of investment banking experience in the healthcare sector, including biotech, pharma, medical devices and diagnostics sectors. Prior to that he spent many years in strategic and operations consulting in multiple industries. Over the course of his career, Mr. Jain has led multiple public offerings for equity and debt, and has provided strategic advice to large as well as small corporations, with respect to mergers, acquisitions, divestitures, and spin-offs. Mr. Jain has executed over $100 billion of transactions, including M&A, equity and debt offerings. Mr. Jain has worked at some of the largest global banks including Mizuho and UBS. Mr. Jain obtained his Bachelors in Electronics Engineering at National Institute of Technology, India and MBA at Cornell University, NY.


Howard Shapland

Non Executive Director

Howard holds a Diploma in Business Studies and has formal training in business development, marketing management, business management and product and project development – primarily in the biotechnology industry. He has over 25 years’ experience in the field. For 15 years he held senior positions with the multinational pharmaceutical company Abbott Laboratories (US). During this time he was based in Australia, Europe and the Middle East.
His company BioVenture Development (established in 2009) provides regulatory and compliance consultancy, business and project development in the biotechnology sector. Howard has worked with International Medical Devices PLC, as Regulatory and Compliance Manager to introduce ISO 9001 and ISO 13485 quality management systems to the group, CE mark medical devices and maintaining regulatory compliance.


Martin O’Donoghue

Recognised as a leading M&A lawyer in numerous editions of the Legal 500, Martin has vast experience in the areas of corporate finance, investment, mergers and acquisitions, joint ventures and intellectual property. He is qualified to practice as a lawyer in several jurisdictions and has advised on transactions spanning the UK, the US, Europe, Africa and Asia. His sector focuses include tech, media, healthcare and biotech. Martin holds a degree in Business & Law from University College Dublin and an MBA from Henley Business School.